Characterization of Ocular Neural Stem Cells

眼神经干细胞的表征

• 批准号: 6525135
• 负责人: Iqbal Ahmad
• 金额: $ 25.73万
• 依托单位: UNIVERSITY OF NEBRASKA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-09-30 至 2004-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6525135
• 关键词: animal genetic material tag; cell differentiation; cell proliferation; cell transplantation; cell type; central nervous system; electrophysiology; epidermal growth factor; eye injury; fibroblast growth factor; flow cytometry; growth factor receptors; histogenesis; immunocytochemistry; laboratory rat; mitogens; mixed tissue /cell culture; neurons; neurotrophic factors; polymerase chain reaction; retina; stem cells; uvea ciliary body

Establishing cellular diversity is central to the development, structure and function of the brain. Underlying this diversity is a population of neural progenitors with stem cell properties that generates region-specific neurons and glia. Therefore understanding the molecular and cellular biology of neural progenitors holds the key to the mechanism(s) of development of specific regions of the brain including retina. Recapitulation of these developmental mechanisms is likely to open new avenues for treating the impairments of functions that arise due to death of specific neuronal populations as in the case of retinitis pigmentosa and macular degeneration. With these objectives in mind we have proposed to characterize neural progenitors isolated from derivatives of ocular neuroepithelium, the retina and the ciliary body, for their proliferative capacity, self-renewal, maintenance, and developmental potentials in vivo and in vitro under the following specific aims. First, proliferative and differentiation potentials of ocular progenitors will be characterized in the context of their responsiveness to the mitogens, FGF2 and EGF. We will use flow cytometry to examine their proliferation and survival, limiting dilution analysis to estimate their frequency to form clones, immunocytochemical and RT-PCR analyses of cell-type specific markers to test their multipotentiality, and clonal density culture to determine their self-renewal capacity. In addition, we will determine the distribution of mitogen receptors in different sub-populations of ocular progenitors in order to understand the basis of their responsiveness and relationships. Second, the role of Notch signaling in the maintenance of ocular progenitors will be evaluated. We will analyze proliferation and differentiation of these cells in response to gain-of-function and loss-of-function perturbations of Notch signaling. Third, the differentiation potentials of ocular progenitors will be determined in vitro in conditions that promote differentiation. We will use immunocytochemical and electrophysiological analyses to evaluate their ability to acquire specific phenotypes in response to growth factors and neurotrophins, and in co-culture conditions. Fourth, the potential of ocular progenitors to generate site-specific cells in vivo will be evaluated. We will use homotopic and heterotopic transplantation and in vivo activation of progenitors in response to injuries to achieve the aim. Accomplishing these aims will provide valuable information about the underlying mechanism(s) of retinal development and will allow the use of ocular progenitors in stem cell therapy to address degenerative changes in the retina whether inherited, age-related or due to injuries.

建立细胞多样性对于大脑的发育、结构和功能至关重要。 这种多样性的基础是一群具有干细胞特性的神经祖细胞，可以产生区域特异性神经元和神经胶质细胞。因此，了解神经祖细胞的分子和细胞生物学是了解包括视网膜在内的大脑特定区域发育机制的关键。这些发育机制的概括可能会为治疗由于特定神经元群体死亡而引起的功能损伤（例如色素性视网膜炎和黄斑变性）开辟新的途径。 考虑到这些目标，我们建议根据以下具体目标，表征从眼神经上皮、视网膜和睫状体的衍生物中分离出的神经祖细胞的增殖能力、自我更新、维持和体内和体外发育潜力。 首先，眼祖细胞的增殖和分化潜力将在其对有丝分裂原、FGF2和EGF的反应性的背景下进行表征。 我们将使用流式细胞术来检查它们的增殖和存活，使用有限稀释分析来估计它们形成克隆的频率，对细胞类型特异性标记物进行免疫细胞化学和 RT-PCR 分析来测试它们的多潜能性，并使用克隆密度培养来确定它们的自我更新能力。 此外，我们将确定丝裂原受体在眼祖细胞不同亚群中的分布，以了解它们的反应性和关系的基础。其次，将评估Notch信号在维持眼祖细胞中的作用。 我们将分析这些细胞响应 Notch 信号传导的功能获得和功能丧失扰动的增殖和分化。 第三，将在促进分化的条件下在体外测定眼祖细胞的分化潜力。我们将使用免疫细胞化学和电生理学分析来评估它们响应生长因子和神经营养素以及在共培养条件下获得特定表型的能力。 第四，将评估眼祖细胞在体内产生位点特异性细胞的潜力。 我们将利用同位和异位移植以及体内激活祖细胞以响应损伤来实现这一目标。 实现这些目标将提供有关视网膜发育的潜在机制的有价值的信息，并将允许在干细胞治疗中使用眼祖细胞来解决视网膜的退行性变化，无论是遗传性的、与年龄相关的还是由于损伤引起的。